MET Dependence Oversteps EGFR Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib‐Resistant MET ‐Amplified, EGFR ‐Mutated Non‐Small Cell Lung Cancer
Thoracic Cancer · 2026-07 · 17 (13)
DOI: 10.1111/1759-7714.70334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 30.06.2026. Verfasst von Yuri Yagami und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan. Hauptthemen laut MEDLINE: Aniline Compounds, Proto-Oncogene Proteins c-met, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Naito Foundation.
Abstract (Originalsprache)
Background
Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) have substantially improved the clinical outcomes of patients with EGFR ‐mutated non‐small cell lung cancer (NSCLC), most patients ultimately develop acquired resistance. MET amplification is a common resistance mechanism to EGFR‐TKIs; however, its effects on receptor dimerization and the resulting dependence on EGFR or MET signaling have not been fully elucidated.
Methods
We established a classical lung cancer cell line model with acquired resistance to osimertinib, a third‐generation EGFR‐TKI, through exposure to the drug (HCC827OR). Activation profiles of phospho‐receptor tyrosine kinases and genomic alterations were investigated, and drug sensitivity to osimertinib and the MET‐TKI savolitinib was evaluated. EGFR and MET signaling status and dimerization/interaction of EGFR, MET, and ERBB3 were analyzed. In addition, exogenous MET overexpression was introduced into parental HCC827 cells to assess its effects on drug sensitivity and receptor dimerization.
Results
HCC827OR cells exhibited MET amplification and showed sensitivity to savolitinib monotherapy. ERBB3 phosphorylation correlated with the efficacy of the TKIs. Consistently, we found reduced interaction between EGFR and ERBB3 and increased interaction between MET and ERBB3 in HCC827OR cells. MET homodimers and MET‐EGFR interaction increased while EGFR homodimers decreased in those cells. Exogenous MET overexpression in the parental cells partially recapitulated the drug‐resistant phenotype, showing partial sensitivity to savolitinib, increased MET homodimers, and decreased EGFR homodimers.
Conclusions
MET amplification alters the balance of EGFR/MET/ERBB3 dimerization, leading to a shift in signaling dependence from EGFR to MET. These findings provide insight into therapeutic strategies for EGFR ‐mutated NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Biochemistry, Kitasato University School of Medicine, Sagamihara, Japan.
- Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.
ORCID-Profile: Takashi Sato, Ryosuke Inoue, Ryouhei Tsutsumi, Yoshiro Nakahara, Jiichiro Sasaki, Katsuhiko Naoki
Förderung
- Japan Society for the Promotion of Science
- Naito Foundation
Zitieren
APA
Yagami, Y., Sato, T., Yamamoto, H., Matsuo, H., Inoue, R., Tsutsumi, R., Kakegawa, M., Nakahara, Y., Sasaki, J., & Naoki, K. (2026). MET Dependence Oversteps EGFR Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib‐Resistant MET ‐Amplified, EGFR ‐Mutated Non‐Small Cell Lung Cancer. Thoracic Cancer, 17(13). https://doi.org/10.1111/1759-7714.70334
Vancouver
Yagami Y, Sato T, Yamamoto H, Matsuo H, Inoue R, Tsutsumi R, et al. MET Dependence Oversteps EGFR Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib‐Resistant MET ‐Amplified, EGFR ‐Mutated Non‐Small Cell Lung Cancer. Thoracic Cancer. 2026;17(13). doi:10.1111/1759-7714.70334
BibTeX
@article{Yagami2026,
author = {Yagami, Yuri and Sato, Takashi and Yamamoto, Hiroki and Matsuo, Hiromi and Inoue, Ryosuke and Tsutsumi, Ryouhei and Kakegawa, Mikiko and Nakahara, Yoshiro and Sasaki, Jiichiro and Naoki, Katsuhiko},
title = {MET Dependence Oversteps EGFR Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib‐Resistant MET ‐Amplified, EGFR ‐Mutated Non‐Small Cell Lung Cancer},
journal = {Thoracic Cancer},
year = {2026},
volume = {17},
number = {13},
doi = {10.1111/1759-7714.70334}
}
EUVIMED